NEW YORK (GenomeWeb) – Thermo Fisher Scientific has entered into a $2 billion bridge credit agreement, a $2 billion term loan agreement, and a $2.5 billion revolving credit agreement, the company said in a July 1 filing with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.